U.S. Markets closed

Vycor Medical, Inc. (VYCO)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.1790+0.0340 (+23.45%)
At close: 11:31AM EDT

Vycor Medical, Inc.

951 Broken Sound Boulevard
Suite 320
Boca Raton, FL 33487
United States
561 558 2000

IndustryMedical Devices
Full Time Employees6

Key Executives

NameTitlePayExercisedYear Born
Mr. Peter C. ZachariouCEO & DirectorN/AN/A1962
Mr. David Marc CantorPres & DirectorN/AN/A1966
Mr. Adrian Christopher LiddellChairman, CFO & DirectorN/AN/A1959
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Vycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. It operates in two segments, Vycor Medical and NovaVision. The Vycor Medical segment provides devices for neurosurgery comprising ViewSite Brain Access System, a retraction and access system for brain and spine surgeries. The NovaVision segment offers non-invasive computer-based rehabilitation targeted at people who have impaired vision as a result of stroke or other brain injury. Vycor Medical, Inc. has a license and transition agreement with HelferApp GmbH, which grants HelferApp the license to provide NovaVision's products and therapies to patients and professionals in Germany, Austria, and Switzerland. The company primarily serves hospitals and medical professionals. Vycor Medical, Inc. was incorporated in 2005 and is headquartered in Boca Raton, Florida.

Corporate Governance

Vycor Medical, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.